2021.02.26
Organization and Personnel Changes
February 26,2021
J-Pharma Co., Ltd.
Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes upon the approval of extraordinary meeting of shareholders on February 25, 2020.
１．Transition to a company with board of company auditors
２．Changes of Board Members
① New Board Members
| Title | Name | Current Position |
| External Director | Sadashi Suzuki | Representative, Newton Biocapital Partners, Japan |
| External Director | Shinichiro Komoto | Partner, Eight-Roads Ventures Japan |
② New Auditors
| Title | Name | Current Position |
| Audit & Supervisory Board Member |
Tadashi Takeuchi | Small and Medium Enterprise Management Consultant |
| Audit & Supervisory Board Member |
Teruhisa Tajima | Certified Public Accountant Representative, Tajima CPA firm |
| Audit & Supervisory Board Member |
Toshio Furuta | Lawyer Representative, Clair Law firm |
③ Retired Audit & Supervisory Board Member
| Name |
| Yukou Ikuta |
| Futoshi Nakamura |
【Reference】
All the Board Members as of February 26
| Title | Name | Current Position |
| Chief Executive Officer | Masuhiro Yoshitake | ― |
| Director, Corporate Planning | Yoshinori Bamba | ― |
| Director, R&D | Takehiro Igawa | ― |
| External Director | Satoe Otsubo | Director, Venture Investment Team
Shinsei Corporate Investment |
| External Director | Sadashi Suzuki | Representative, Newton Biocapital Partners, Japan |
| External Director | Shinichiro Komoto | Eight-Roads Ventures Japan |
| External Director | Toshiyuki Mori | Representative, TM Partners |
| Audit & Supervisory Board Member | Tadashi Takeuchi | Small and Medium Enterprise Management Consultant |
| Audit & Supervisory Board Member | Teruhisa Tajima | Certified Public Accountant Representative, Tajima CPA firm |
| Audit & Supervisory Board Member | Toshio Furuta | Lawyer Representative, Clair Law firm |
Contact: Tomohiro Yuzawa, Director,
Corporate Management Dept.
Tel: 045-506-1155
info@j-pharma.com
